The Ratings Game: Better Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatment
The Ratings Game: Better Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatment
#earnings after the close https://t.co/lObOE0dgsr $SKLZ $BB $IZEA $AEHR $GOEV $RUM $SPRO $BRZE $ACRX $CSSE $ARCE $ASTS $UGRO $GAN $CURI $AREC $DARE $LOV $PPSI $YMAB $SIEN $PIII $BIOR $SLGG $DUOT $EYEN $ASTR $ELDN $NRXP $KINS $SHPW $THRN $THMO $SASI $BTTX $GVP $VVOS $WULF… https://t.co/eNTvXTO492
5.45KUSD
Type
Common Stock
Exchange
OTCMKTS
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US08773T1043
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.25
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.1
Wall Street Target Price
5.25
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
-0.21
EPS Estimate Next Quarter
-0.19
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
-674,000
EBITDA
-29,175,000
Profit Margin
0.00%
Return On Assets TTM
-95.05%
Return On Equity TTM
-1021.64%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-1.1
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
49559.4078
Price Book MRQ
2.289
Enterprise Value Revenue
74299
Enterprise Value EBITDA
0
162.19
7.06%188.50
5.08%586.54
4.37%590.13
1.16%79.34
0.48%304.00
0.05%108.89
0.04%91.99
-0.65%515.02
-0.49%444.38
-0.39%